Scinai Immunotherapeutics Ltd. (SCNI) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Scinai Immunotherapeutics Ltd. (SCNI) closed at USD 0.90 on 2026-10-15, a change of -93.8 % over the past year, with a market capitalization of USD 1.02M.

Scinai Immunotherapeutics Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Scinai Immunotherapeutics Ltd. key figures

Previous close

USD 0.90 (2026-10-15)

1-year change

-93.8 %

Market cap

USD 1.02M

Enterprise value

USD 6.98M

P/E ratio (trailing)

0.03

P/E ratio (forward)

n/a

EPS (trailing)

28.07

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.07

Revenue growth

146 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.01

Employees

45

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical method development, process development, and cGMP manufacturing of clinical-stage materials to early-stage biotechnology companies. It has collaboration partnerships with Max Planck Society and University Medical Center Gottingen for the development of NanoAb candidates; and Recipharm Israel Ltd for the development of biologics and small-molecule programs. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is based in Jerusalem, Israel.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Scinai Immunotherapeutics Ltd. and compare it with other stocks.